MedPath

Onkovis GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2013-09-13
Last Posted Date
2018-08-07
Lead Sponsor
Onkovis GmbH
Target Recruit Count
383
Registration Number
NCT01942200
Locations
🇩🇪

Practice, Naunhof, Germany

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2013-04-25
Last Posted Date
2018-05-23
Lead Sponsor
Onkovis GmbH
Target Recruit Count
324
Registration Number
NCT01840280
Locations
🇩🇪

Practice, Werdau, Germany

A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2012-08-17
Last Posted Date
2018-07-16
Lead Sponsor
Onkovis GmbH
Target Recruit Count
770
Registration Number
NCT01668108
Locations
🇩🇪

Practice, Plauen, Germany

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2012-06-07
Last Posted Date
2015-06-04
Lead Sponsor
Onkovis GmbH
Target Recruit Count
371
Registration Number
NCT01614002
Locations
🇩🇪

Practice, Zwickau, Germany

🇩🇪

Hospital, Leipzig, Germany

🇩🇪

Clinic, Torgau, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.